Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18037577rdf:typepubmed:Citationlld:pubmed
pubmed-article:18037577lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18037577lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:18037577lifeskim:mentionsumls-concept:C0206180lld:lifeskim
pubmed-article:18037577lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:18037577lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:18037577pubmed:issue5lld:pubmed
pubmed-article:18037577pubmed:dateCreated2008-3-31lld:pubmed
pubmed-article:18037577pubmed:abstractTextPrimary cutaneous CD30+ anaplastic large-cell lymphoma (CALCL) is a relatively rare and indolent variant of cutaneous T-cell lymphoma (CTCL). This report examines the response of localized disease to radiation alone.lld:pubmed
pubmed-article:18037577pubmed:languageenglld:pubmed
pubmed-article:18037577pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18037577pubmed:citationSubsetIMlld:pubmed
pubmed-article:18037577pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18037577pubmed:statusMEDLINElld:pubmed
pubmed-article:18037577pubmed:monthAprlld:pubmed
pubmed-article:18037577pubmed:issn0360-3016lld:pubmed
pubmed-article:18037577pubmed:authorpubmed-author:WilsonLynn...lld:pubmed
pubmed-article:18037577pubmed:authorpubmed-author:McNiffJennife...lld:pubmed
pubmed-article:18037577pubmed:authorpubmed-author:LundMolly WMWlld:pubmed
pubmed-article:18037577pubmed:authorpubmed-author:YuJames BJBlld:pubmed
pubmed-article:18037577pubmed:issnTypePrintlld:pubmed
pubmed-article:18037577pubmed:day1lld:pubmed
pubmed-article:18037577pubmed:volume70lld:pubmed
pubmed-article:18037577pubmed:ownerNLMlld:pubmed
pubmed-article:18037577pubmed:authorsCompleteYlld:pubmed
pubmed-article:18037577pubmed:pagination1542-5lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:meshHeadingpubmed-meshheading:18037577...lld:pubmed
pubmed-article:18037577pubmed:year2008lld:pubmed
pubmed-article:18037577pubmed:articleTitleTreatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.lld:pubmed
pubmed-article:18037577pubmed:affiliationDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040, USA.lld:pubmed
pubmed-article:18037577pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18037577pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18037577lld:pubmed